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Abstract
Background: The uptake and trans-placental trafficking of fatty acids from the maternal blood into the fetal circulation are
essential for embryonic development, and involve several families of proteins. Fatty acid transport proteins (FATPs) uniquely
transport fatty acids into cells. We surmised that placental FATPs are germane for fetal growth, and are regulated during
hypoxic stress, which is associated with reduced fat supply to the fetus.
Methodology/Principal Findings: Using cultured primary term human trophoblasts we found that FATP2, FATP4 and FATP6
were highly expressed in trophoblasts. Hypoxia enhanced the expression of trophoblastic FATP2 and reduced the
expression of FATP4, with no change in FATP6. We also found that Fatp2 and Fatp4 are expressed in the mouse amnion and
placenta, respectively. Mice deficient in Fatp2 or Fatp4 did not deviate from normal Mendelian distribution, with both
embryos and placentas exhibiting normal weight and morphology, triglyceride content, and expression of genes related to
fatty acid mobilization.
Conclusions/Significance: We conclude that even though hypoxia regulates the expression of FATP2 and FATP4 in human
trophoblasts, mouse Fatp2 and Fatp4 are not essential for intrauterine fetal growth.
Citation: Mishima T, Miner JH, Morizane M, Stahl A, Sadovsky Y (2011) The Expression and Function of Fatty Acid Transport Protein-2 and -4 in the Murine
Placenta. PLoS ONE 6(10): e25865. doi:10.1371/journal.pone.0025865
Editor: Hongmei Wang, Institute of Zoology, Chinese Academy of Sciences, China
Received May 6, 2011; Accepted September 13, 2011; Published October 20, 2011
Copyright:  2011 Mishima et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: The project was supported by the Kobe University Overseas Visiting Program for Young Researchers (to MM), National Institutes of Health
R01AR049269 (to JHM), and National Institutes of Health R01ES011597 (to YS). The funders had no role in study design, data collection and analysis, decision to
publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: ysadovsky@mwri.magee.edu
Introduction
Both the human and mouse placenta are hemochorial, with
fetal-derived trophoblasts bathed in maternal blood, and are thus
well-positioned to regulate placental transport functions, including
transport of oxygen, nutrients, and waste products between the
maternal and fetal blood. Among transported nutrients, the uptake
and trafficking of fatty acids is critical for embryonic development
and growth in all eutherians, particularly during the second half of
pregnancy, when the fetal/placental growth ratio is markedly
increased, corresponding to increasing fetal caloric demands [1–
3]. Transported essential fatty acids (linoleic acid, and a-linolenic
acid) are metabolized into long chain poly-unsaturated fatty acids
(LCPUFAs), and are necessary for development of vital organs
such as the heart and lung. A particularly high amount of
arachidonic acid and docosahexaenoic acid is needed for
development of the brain and retina [3–8]. Fatty acids are also
essential for biosynthesis of membrane phospholipids, myelin,
gangliosides, glycolipids and sphingolipids, and for production of
signaling eicosanoids [9–12]. Albumin-bound free fatty acids
(FFA), VLDL, and chylomicrons in the maternal circulation are
the major source of fatty acids to the placenta, and require the
action of trophoblastic triglyceride hydrolase for liberation of FFA
and transport across the trophoblastic microvillous membrane
[13–15]. The mechanisms underlying trophoblast fatty acid
uptake and trafficking are largely unknown. Membrane-bound
and cytoplasmic fatty acid binding proteins (FABPs) are expressed
in trophoblasts, but their function in intracellular trafficking of
fatty acids in trophoblasts is unknown [16–18].
Cytoplasmic FFAs bound to fatty acid binding proteins (FABPs)
are targeted for metabolism or storage in lipid droplets, which are
dynamic organelles that actively store neutral lipids (such as
triglycerides, cholesteryl esters and retinol esters) [19–21]. In
addition to their neutral fats, lipid droplets are encased within a
layer of amphipathic lipids, and coated by lipid droplet-associated
(PLIN) proteins that regulate the assembly, maintenance, and
composition of lipid droplets, as well as lipolysis and lipid efflux
[22–25].
The family of fatty acid transport proteins (FATPs, solute
carrier family 27, SLC27) is an evolutionarily conserved group of
integral trans-membrane proteins which, along with fatty acid
translocase (FAT/CD36), mediate cellular uptake of long-chain
and very long chain fatty acids. This prevalent, saturable, carrier-
regulated process is distinct from the less common, passive (‘‘flip-
flop’’) membrane diffusion [26–28]. FATPs comprise a family of
six highly homologous proteins, which are expressed primarily in
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highly expressed by epithelial cells of the visceral endoderm and
localizes to the brush-border of extraembryonic endodermal cells
[31]. It is hypothesized that FATP1, FATP2, and FATP4 are
bifunctional, exhibiting both transport and acyl-CoA synthase
activities, which facilitate fatty acid influx across biological
membranes [32–34].
The expression of placental FATPs and their regulation in this
tissue is largely unknown. We recently showed that ligand-
stimulated PPARg enhances the expression of FATP1 and FATP4
as well as PLIN2 in primary human trophoblast (PHT) [35], and
that hypoxic trophoblasts retain neutral lipids in the form of lipid
droplets (35, and manuscript in preparation). In this study we
sought to identify key FATPs that are expressed in the human
placenta and regulated during hypoxic stress, and use Fatp mutant
mice to decipher the function of relevant FATPs in vivo.
Results
We initially examined the expression of FATP transcripts in the
human placenta and in isolated primary term trophoblasts (PHTs),
and compared the level of FATP expression to that of other human
tissues, serving as controls. Because hypoxia increases the
accumulation of lipid droplets in trophoblasts [35], we also
assessed the expression of FATPs in hypoxic PHT cells. As shown
in Fig. 1A, FATP2, FATP4, and FATP6 are clearly expressed in the
placenta and in PHT cells, with weaker expression of FATP1 and
FATP3. FATP5 is not expressed in the human placenta. As control,
we also assessed the expression of the lipid droplet–associated
(PLIN) transcripts, and detected the expression of PLIN2 and
PLIN3, but not the other members of this family. Among the
highly expressed FATPs, we found that hypoxia enhanced the
expression of FATP2, but diminished the expression of FATP4,
with no change in FATP6 (Fig. 1B). Notably, the weakly expressed
FATP1 was also increased in hypoxia. The increase in PLIN2 in
hypoxic PHTs (Fig. 1B) was expected [36], and suggests lipid
droplet accumulation in hypoxic PHT cells. Together, these data
indicate that placental FATP2 and FATP4 are relatively highly
expressed in primary human trophoblasts, and that hypoxia has an
opposite influence on their expression in human trophoblasts.
Therefore, our subsequent analysis centered on FATP2 and
FATP4.
To gain insight into the role of placental FATP2 and FATP4 in
vivo, we initially sought to examine the expression of Fatps in
placentas of wild type C57Bl/6 mice. We found several differences
in Fatp expression between human and murine placentas. The
near term mouse placenta expresses primarily Fatp1, Fatp3, Fatp4,
and Fatp6 (Fig. 2A). Interestingly, Fatp2 is expressed mainly in the
mouse amnion, but not in the placenta (Fig. 2A). We confirmed
the expression pattern of FATP2 and FATP4 proteins in the
placenta and amnion (Fig. 2B–C).
The expression of Fatps in other mouse organs was similar, but
not identical, to that in humans (compare Fig. 1A–2A). The
expression pattern of murine Plins was similar to that of human
tissues, with weak expression of Plin4 in the mouse placenta.
Hypoxia had a weak and statistically insignificant effect on the
expression of relevant murine Fatps and Plins in both the placenta
and the amnion (Fig. 2D–E). As a control, we showed reduced
expression of placental transferrin receptor (Tfrc), a marker of
hypoxic mouse placenta [37,38].
We used ISH to localize the expression of Fatp2, Fatp4, and
Fatp6 at E7.5 (prior to establishment of maternal-fetal trafficking),
E12.5 (after maternal-fetal trafficking is initiated), and E17.5 (near-
term placenta, Fig. 3). None of the three Fatps were definitively
detected at E7.5. Using renal cortical expression of Fatp2 as
positive control [39], we found that Fatp2 was expressed in the
murine amnion but not in the placenta proper at E12.5 and E17.5
(Fig. 3, A–E). Similarly, Fatp4 was expressed in amnion at E12.5,
and exhibited weak, relatively diffuse placental expression at E12.5
and E17.5. This was confirmed using Fatp4 expression in placentas
derived from Fatp4 transgenic mice (Fig. 3I), and using Fatp4
expression in the intestinal villous epithelium as positive control
(Fig. 3J). Fatp6 was primarily detected in the spongiotrophoblast at
E12.5 and E17.5, but not at E7.5 clearly (Fig. 3, L–O).
We next sought to assess the impact of Fatp2 or Fatp4 deficiency
on the murine placenta. Crossing heterozygous Fatp2 or Fatp4
males and females, we found that at E17.5 Fatp2 or Fatp4 deficient
fetuses were indistinguishable from their wild type littermates in
either standard or hypoxic conditions with respect to litter size,
genotype distribution, placental and embryo weight (Fig. 4). In
Figure 1. FATP and PLINs transcripts expression in PHT cells,
human placentas and other tissues. (A) Expression of FATP1-6 and
PLIN1-5 in diverse human tissues and PHT cells in standard or hypoxic
conditions. Transcripts were detected by standard RT-PCR (representa-
tive results, n=3). (B) RT-qPCR analysis of FATP1, 2, 3, 4, 6 and PLIN2 and
3 in standard vs. hypoxic PHT cells (n=5). * denotes p,0.05, ** denotes
p,0.01.
doi:10.1371/journal.pone.0025865.g001
FATP2 and FATP4 in the Placenta
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in either normal or hypoxic placenta (data not shown). Because
FATPs play a role in cellular fatty acid uptake, we examined the
accumulation of neutral fat, as well as triglyceride levels, in the
placentas of wild type and Fatp2 or Fatp4 deficient mice. Oil Red
O staining (Fig. 5A–C) and Sudan Black B staining (Fig. 5D–F) of
placentas from all genotypes showed a similar pattern of diffuse fat
staining, with more abundant fat in the decidua. This expression
pattern was unchanged in hypoxic placentas (data not shown).
Similarly, the concentration of placental triglycerides was also
Figure 2. Fatp and Plin transcript expression in mouse
placentas and other tissues. (A) Expression of Fatp1-6, Plin1-5 in
diverse mouse tissues and in the placenta (E17.5), amnion (E17.5),
placenta (E10.5), and embryo (E10.5), detected by standard RT-PCR
(representative results, n=3). (B) Western blot analysis of FATP2. (C)
Western blot analysis of FATP4. (D) RT-qPCR of Tfrc, Fatp1, 3, 4, 6, and
Plin2, 3 in mouse placentas under standard vs. hypoxic conditions
(n=8). (E) RT-qPCR of Tfrc, Fatp1, 2, 4, and Plin2, 3 in mouse amnion
under standard vs. hypoxic conditions (n=10). * denotes p,0.05.
doi:10.1371/journal.pone.0025865.g002
Figure 3. ISH for detection of Fatp2, Fatp4 and Fatp6
expression in the mouse placenta. Fatp2 expression in the mouse
embryo at E7.5 (A), placenta at E12.5 (B) and at E17.5 (C), and kidney (D).
Arrowheads point to the amnion. Fatp4 expression in mouse embryo at
E7.5 (F), placenta at E12.5 (G) and at E17.5 (H), in the Fatp4 transgenic
placenta (I) and in the small intestine (J). Fatp6 expression in mouse
embryo at E7.5 (L), placenta at E12.5 (M) and at E17.5 (N). Negative
controls using a sense probe are shown in E, K, O. Scale bars=0.5 mm.
doi:10.1371/journal.pone.0025865.g003
FATP2 and FATP4 in the Placenta
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significant increase in triglyceride concentration in the hypoxic
Fatp2 KO placenta (Fig. 5G). Lastly, we used quantitative RT-
PCR to rule out the possibility that the expression of other Fatps
might compensate for the reduced levels of Fatp2 or Fatp4.A s
shown in Fig. 6, the expression of Fatp2 or Fatp4 was appropriately
reduced in the respective placentas and amnion tissues, with
reduced expression in placental Fatp6 or Fatp3 in the Fatp2 and
Figure 4. The feto-placental phenotype of Fatp2 and Fatp4 deficient mice. The litter size, genotype distribution, placental and embryo
weight at E17.5 in standard or hypoxic conditions after cross-breeding of heterozygous pregnant mice. (A) Fatp2 analysis, (B) Fatp4 analysis. The
graphs depict placenta and embryo weight. * denotes p,0.05.
doi:10.1371/journal.pone.0025865.g004
Figure 5. The effect of Fatp2 or Fatp4 deficiency on the levels of neutral lipids in the mouse placenta. Frozen sections stained with oil
Red O (A–C) or with Sudan Black B (D–F) of wild type, Fatp2 KO, or Fatp4 KO at E17.5. Scale bars=1 mm and 100 mm in larger panels and insets,
respectively. (G) Triglyceride concentration of Fatp2 wild type or KO (left panel), or Fatp4 wild type or KO (right panel) in standard or hypoxic
condition (n=5 for each strain and each condition). * denotes p,0.05.
doi:10.1371/journal.pone.0025865.g005
FATP2 and FATP4 in the Placenta
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Plin2 or Plin3 exhibited a compensatory increase in expression.
Discussion
The uptake, mobilization and efflux of fatty acids are critical for
fetal growth, with fetuses of malnourished pregnant women being
at risk for intrauterine growth restriction [10,14,40,41]. Several
observations regarding FATPs led us to interrogate the expression
and function of placental FATPs: (a) hypoxic human trophoblasts
accumulate neutral lipids with lipid droplets [35], and manuscript
in preparation], (b) PPARg/RXR increase trophoblastic FATP1
and FATP4 expression, reduce FATP2 expression, and enhance
trophoblast uptake of fatty acids and lipid droplet accumulation
[42], and (c) inhibition of p38 (which mimics key aspects of PPARg
deficiency) also up-regulates FATP2 and down-regulates FATP4
expression [42]. We found that among FATPs, FATP2, FATP4
and FATP6 are expressed in human trophoblasts, and that hypoxia
enhanced FATP2 and reduced FATP4 expression levels. These
data, which are opposite of the effect of PPARg/RXR signaling on
FATP2 and FATP4, suggest that FATP2 and FATP4 play a role
in trophoblast fatty acid trafficking. We therefore used pregnant
mice to assess the function of FATP2 and FATP4 in the placenta
in vivo. Although the human and mouse placenta share many
structural, functional, and gene expression patterns [43,44], there
are marked morphological and functional differences between
placentas of the two species, including differences in transport
functions [45–47]. Whereas FATP4 was expressed in both the
human and murine placenta, the expression of murine Fatp2 was
restricted to the amnion. Unlike the expression changes in human
trophoblastic FATP2 and FATP4 when cultured in hypoxic
atmosphere, we found no difference in the expression of murine
placental Fatp2 and Fatp4 between standard and hypoxic
conditions in vivo.
We produced hypoxia during the latter part of mouse
pregnancy using an O2 concentration of 12% for 6 days, which
is similar to the level of hypoxia used by others and us [48,49]. The
most suitable degree of hypoxia for cultured PHT cells remains
controversial. Low oxygen tension (pO2 of 15–20 mmHg)
characterizes the early human placenta, before maternal blood
begins to perfuse the intervillous space, with a rise to ,55 mmHg
after 12 weeks of pregnancy [50,51]. Placental hypoxia is
abnormal after that gestational age [52,53]. Exposure of cultured
third trimester trophoblasts to pO2,1%, as we chose in our
experiments, is commonly used to model hypoperfusion-induced
villous injury [54–56]. Notably, the differences between our in vitro
analysis using PHT cells and intact mouse placentas likely reflect
inter-species differences in expression patterns and functions of
FATPs. Moreover, there is a clear dissimilarity between exposure
to hypoxia in vitro and in vivo, where the response of purified
cultured cells to extreme hypoxia might be different from that of
intact tissue, which is exposed to marked, yet life-sustaining
hypoxia.
Genetic ablation of murine Fatp2 and Fatp4 expression did not
lead to any functional consequences with respect to feto-placental
growth, and specifically, lipid accumulation. These data are
consistent with those of Heinzer et al [57], which did not
specifically focus on embryonic development, yet reported normal
growth, behavior and activity of Fatp2 KO mice. Moulson et al
[58] reported that Fatp4 KO mice died soon after birth, with shiny,
tight, thick skin. This phenotype was reproduced by Herrmann
et al [59,60], who showed that epidermal-specific conditional Fatp4
KO mice exhibited similar morphological abnormalities as
embryos, indicating that the skin-related abnormalities of Fatp4
KO fetuses reflect fetal maldevelopment and not placental
dysfunction. In addition, Gimeno et al [61] demonstrated early
embryonic lethality in Fatp4 KO mice, possibly related to the
expression of FATP4 in the extraembryonic endoderm. Interest-
ingly, two other membrane-related fatty acid transporters,
FABPpm and CD36 (FAT), are also expressed in the murine
placenta, primarily in the labyrinth and junctional zone [17].
While a knockout mouse model for FABPpm has not been
Figure 6. The effect of Fatp2 or Fatp4 deficiency on the expression of other Fatps or Plins in the mouse placenta. RT-qPCR of Fatps,
Plin2 and Plin3 in the placenta or amnion, comparing expression in WT to KO placenta. Data include only relevant FATPs (A) Fatp2 WT or KO (n=12
each) (B) Fatp4 WT or KO. * denotes p,0.05, ** denotes p,0.01.
doi:10.1371/journal.pone.0025865.g006
FATP2 and FATP4 in the Placenta
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placenta –related phenotype [62].
Although we ruled out significant compensatory changes in
placental Fatp expression in Fatp2-o rFatp4-deficient mice, we
cannot rule out functional redundancy among fatty acid
transporters. Such redundancy is unlikely, though, because the
expression of the different Fatp’s in the placenta is dissimilar.
Furthermore, as noted above, the phenotype of Fatp2- and Fatp4 -
deficient mice in non-placental tissues does not overlap. Our data
are the first to show the expression of Fatp6, hitherto known to be
expressed in the human heart and bovine mammary tissue
[12,63], in human trophoblasts and mouse placentas, as well as in
the female and male gonads. It is possible that FATP6 plays a role
on fat trafficking in the placenta as well as in other organs, which
may be redundant with the function of other FATPs.
While critical experiments that might have uncovered the role
of FATPs in the human placenta cannot be ethically performed,
our results underscore limitations in the use of animal models to
inform human biology. Mutations in human FATP2 are currently
unknown. Several mutations in human FATP4 are associated with
ichthyosis prematurity syndrome, where preterm delivery is
related to polyhydramnios, not a placental function [64], or with
congenital verruciform hyperkeratosis [65]. New animal models as
well as manipulation of FATP expression using ex vivo human
samples might be necessary in order to fully analyze the role of
FATPs in placental fat uptake and trafficking.
Materials and Methods
Primary human trophoblast (PHT) isolation and culture
Placental tissue samples were collected by the Obstetrical
Specimen Procurement Unit at Magee-Womens Hospital of the
University of Pittsburgh Medical Center. Collection was conduct-
ed under an approved exempt protocol by the Institutional Review
Board of the University of Pittsburgh. Patients provided written
consent for the use of de-identified, discarded tissues for research
upon admittance to the Hospital. PHT cells were isolated from
term human placentas (n=5) and cultured as we previously
described [55]. Cells were cultured in an atmosphere of 20% O2
with 5% CO2 at 37C as standard condition, or in O2,1% in a
hermetically enclosed incubation chamber (Thermo Electron,
Marietta, OH), where indicated [55]. Cells were harvested after
48 h and processed as detailed below.
Mouse breeding, genotyping and exposure to hypoxia
Our experiments were conducted under protocol number
0806669-B4, which was approved by the Institutional Animal
Care and Use Committee of University of Pittsburgh. Fatp2
(Slc27a2tm1Kds) heterozygous C57Bl/6 mice harboring a targeted
mutation in the Fatp2 gene were generously provided by Dr. Kirby
Smith (Johns Hopkins). Fatp4 heterozygous (Slc27a4/wrfr) C57Bl/
6 mice, which harbor a spontaneous transposon insertion in Fatp4
gene, as well as the Fatp4 overexpressing mouse, were previously
described [66]. Timed matings were carried out by pairing
heterozygous males and females for one night, with the morning
after mating designated as embryonic day 0.5 (E0.5). Pregnancy
was assumed based the presence of vaginal plug and a 10% weight
gain on E10.5. Mice were kept under constant conditions until
E11.5, were given a standard rodent chow and water ad libitum,
and kept on a 12:12 h light-dark cycle in room air. Delivery
typically occurs on E19.5. Exposure to hypoxia, where relevant,
was initiated on E11.5, when the mice were either exposed to
FiO2=12% between E11.5 and E17.5 (hypoxia group) or
normoxia at standard atmospheric conditions. For exposure to
normobaric hypoxia we used a Polymer Hypoxic Glove Box with
a Purge Airlock system with CO2 and O2 control indicators (Coy
Laboratory Products, Grass Lake, MI), which is specifically
designed for experiments in live rodents and regulates ambient
temperature, humidity, and gas composition. Dams were eutha-
nized by CO2 asphyxiation. Embryos and placentas were weighed,
and immediately processed for further analysis (see below). Each
set of analyses included ten pregnant mice, each carrying 6–10
embryos. Fetuses from uterine horns containing only one embryo
were excluded from the final analysis. Genomic DNA was
extracted from embryo tails by the alkaline lysis and boiling
method [67] and genotyped using standard PCR, as previously
described [34,58].
Histological Analysis
For oil Red O staining, 4% PFA-fixed samples were immersed
in 10%, then 20% sucrose in PBS, followed by OCT embedding.
Sections were cut using a cryostat (Cryotome FSE, Thermo
Scientific, Wilmington, DE) at 7 mm thickness, then stained with
oil Red O (Sigma) [68] and counter-stained with hematoxylin or
stained with Sudan Black B (Sigma) and counter-stained with
nuclear fast red.
For detection of Fatp2, Fatp4 and Fatp6 by ISH we used
digoxigenin-labeled cRNA probes, synthesized using digoxigenin
RNA labeling kit (Roche, Basel, Switzerland). Cryosections
(10 mm) of the OCT-embedded placentas were rehydrated in
PBS, digested with proteinase K (10 mg/ml, 5 min at 37 C),
treated with 0.2 N HCl for 10 min at RT, acetylated (0.25% acetic
anhydride in TEA for 10 min at RT), and then hybridized with
cRNA probes overnight at 60 C. Slides were washed four times
with 46SSC, digested with RNaseA (5 mg/ml) for 15 min at 37 C,
and washed twice with 0.56SSC for 15 min at 60 C. Slides were
blocked using 1% blocking reagent (Roche) in maleic acid buffer
(MAB), followed by incubation with anti-DIG-AP antibody
(0.5 U/ml) for 2 h at RT, washed with MABT (MAB with 0.2%
Tween20), and then reacted with BM purple (Roche) with 1 mM
levamisole overnight. The sections were examined using Nikon 90i
microscope (Nikon, Tokyo, Japan) equipped with DS-Ri1 CCD
camera (Nikon).
Standard and quantitative RT-PCR
Total RNA was extracted from PHT cells or from diverse tissues
of eight weeks old mice using TriReagent (MRC, Cincinnati, OH)
according to the manufacturer’s instructions. Some of the analyses
were also performed using Human Total RNA Survey Panel
(Ambion, Austin, CA). RNA samples were treated with DNaseI
using a Turbo DNA-free Kit (Ambion). Complementary DNA
(cDNA) was synthesized from 1 mg of total RNA in 20 mlo f
reaction mixture using High Capacity RNA-to-cDNA Master Mix
(Applied Biosystems, Foster City, CA). Synthesized cDNA samples
were diluted 1:5 in DEPC-treated H2O. RNA quality was assessed
by 260/280 and 260/230 absorbance ratio using NanoDrop
(Thermo). Standard RT-PCR was performed using KOD Xtreme
DNA polymerase (EMD, Gibbstown, NJ) with 2 ml cDNA per
20 ml reaction volume, with amplification in a Veriti thermal
cycler (Applied Biosystems) using the following conditions: 94 C
for 2 min, 35 cycles at 98 C for 10 sec, 60 C for 30 sec, and 68 C
at 30 sec. PCR products were electrophoresed on a 2% TAE
agarose gel and DNA detected using ethidium bromide.
Quantitative RT-PCR was carried out in duplicates using 384
well plates with 2 ml of cDNA per 10 ml of reaction mixture using
SYBR Green PCR master mix (Applied Biosystems). A total of 8–
12 cDNA from mouse samples and five cDNAs from human
samples were used for each analysis. PCR was carried out in
FATP2 and FATP4 in the Placenta
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cation was confirmed using a dissociation curve of the PCR
product. Detection of YWHAZ for human [69] or L32 for mouse
[70] was used as normalization control. The relative expression
change was calculated using the DDCt method [71]. All primers
used in this study are listed in Table S1.
Western blot analysis
Proteins for western blot were prepared from cells using lysis
buffer, and by homogenization in lysis buffer for tissues, as we
previously described [35]. Protein lysates were electrophoresed
using 7.5% sodium dodecyl sulfate (SDS)-polyacrylamide gel at
180 V for 1 h, then transferred to polyvinylidene difluoride
membranes (Biorad, Hercules, CA) at 23 V for overnight. After
blocking with 5% non-fat dried milk in TBST, the membranes
were incubated overnight with rabbit anti-FATP2, FATP4
antibodies as previously described [30] or mouse anti-actin,
Millipore, Bedford, MA) antibodies at 4 C. After washing with
TBST, the membranes were incubated with goat anti-rabbit IgG
peroxidase conjugated (Santa Cruz Biotech, Santa Cruz, CA) and
donkey anti-mouse IgG peroxidase conjgated (Santa Cruz) for 2 h
at RT. Detection was performed with Western Lightning ECL kit
(Perkin Elmer).
Triglyceride Assay
Lipids were extracted from each murine placenta by the Folch
method [72], and triglyceride concentration determined using a
triglyceride spectrophotometer assay kit (Cayman Chemical, Ann
Arbor, MI), detected using a VersaMax microplate reader
(Molecular Devices, Sunnyvale, CA). Five placental fragments,
each 10–20 mg, were used for analysis, and normalized by weight.
Statistics
Statistical analysis was performed using analysis of variance
(ANOVA) with Bonferroni post hoc test for multiple comparisons
of placental and embryo weight, and by Mann-Whitney test for
RT-qPCR and triglyceride assay using Dr SPSS II for Windows
(SPSS, Chicago, IL). Significance was determined at p,0.05.
Supporting Information
Table S1 Primers used in standard and RT-qPCR.
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